EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer

Jinpeng Cen, Jiading Guo, Xianzi Zeng, Xianlu Song, Shengdong Ge, Mingkun Chen, Qianyi Li, Yuzhong Yu, Daojun Lv, Shanchao Zhao

Frontiers in Cell and Developmental Biology · 25.06.2025 · 13

DOI: 10.3389/fcell.2025.1646699 ↗

Kurz gefasst

Korrektur in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 25.06.2025. Verfasst von Jinpeng Cen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CRPCELOVL2androgen receptorenzalutamide resistanceprostate cancer

Autor:innen und Institutionen

  • Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Urology, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Radiotherapy, Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Department of Urology, The Fourth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • First Clinical Medical College, Southern Medical University, Guangzhou, Guangdong, China.

Zitieren

APA

Cen, J., Guo, J., Zeng, X., Song, X., Ge, S., Chen, M., Li, Q., Yu, Y., Lv, D., & Zhao, S. (2025). Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1646699

Vancouver

Cen J, Guo J, Zeng X, Song X, Ge S, Chen M, et al. Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1646699

BibTeX
@article{Cen2025,
  author = {Cen, Jinpeng and Guo, Jiading and Zeng, Xianzi and Song, Xianlu and Ge, Shengdong and Chen, Mingkun and Li, Qianyi and Yu, Yuzhong and Lv, Daojun and Zhao, Shanchao},
  title = {Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fcell.2025.1646699}
}
Kostenlos starten →